Concomitant use may increase risk for supine hypertension due to additive blood pressure-raising effects.
Source: NLP:droxidopa
9 interactions on record
Concomitant use may increase risk for supine hypertension due to additive blood pressure-raising effects.
Source: NLP:droxidopa
Increases risk of hypertension when used concomitantly with midodrine. Avoid concomitant use or monitor blood pressure closely.
Source: NLP:midodrine hydrochloride
One case of hypertensive crisis reported in patient taking recommended doses of selegiline and ephedrine.
Source: NLP:selegiline hydrochloride
Ephedrine may enhance metabolic clearance of dexamethasone, resulting in decreased blood levels and requiring dosage increase.
Source: NLP:dexamethasone
Ephedrine may enhance metabolic clearance of dexamethasone, resulting in decreased blood levels and reduced efficacy.
Source: NLP:dexamethasone 1.5 mg
Ephedrine enhances metabolic clearance of dexamethasone, resulting in decreased blood levels and requiring dosage increase.
Source: NLP:dexamethasone intensol
Ephedrine induces hepatic microsomal enzyme activity and enhances metabolism of prednisolone, requiring increased prednisolone dosage.
Source: NLP:prednisolone sodium phosphate
Renal clearance of alkaline sympathomimetics like ephedrine may be decreased due to alkalinizing action of lactate.
Source: NLP:sodium chloride, sodium lactate, potassium chloride, calcium chloride
Tolcapone did not influence ephedrine's effects on hemodynamic parameters or plasma catecholamine levels; drugs can be co-administered.
Source: NLP:tolcapone